Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Short-term Investments (2020 - 2024)

RAPT Therapeutics' Short-term Investments history spans 5 years, with the latest figure at $60.0 million for Q3 2024.

  • For Q3 2024, Short-term Investments fell 54.07% year-over-year to $60.0 million; the TTM value through Sep 2024 reached $60.0 million, down 54.07%, while the annual FY2023 figure was $111.4 million, 46.99% down from the prior year.
  • Short-term Investments for Q3 2024 was $60.0 million at RAPT Therapeutics, down from $77.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $210.1 million in Q4 2022 and bottomed at $46.7 million in Q1 2020.
  • The 5-year median for Short-term Investments is $130.6 million (2023), against an average of $123.8 million.
  • The largest annual shift saw Short-term Investments soared 91.27% in 2021 before it plummeted 54.07% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $86.6 million in 2020, then soared by 91.27% to $165.6 million in 2021, then rose by 26.86% to $210.1 million in 2022, then crashed by 46.99% to $111.4 million in 2023, then crashed by 46.13% to $60.0 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Short-term Investments are $60.0 million (Q3 2024), $77.8 million (Q2 2024), and $96.3 million (Q1 2024).